Developer docs
API playgroundTry for free, no card

Search company profiles

Actylis

Full company profile

uuid0008eac

Namestring
Actylis
Websiteurl
actylis.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Actylis is a privately held specialty ingredients manufacturer and distributor serving the life sciences, pharmaceutical, nutrition, and specialty chemical industries. Founded in 2022 and headquartered in New York, the company supplies vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to B2B customers including dietary supplement manufacturers, OTC and prescription pharmaceutical producers, and industrial chemical users across North America. Its product portfolio includes acquired brands such as Pharm-RX (acquired October 2024) and specialty solvent distribution such as PCBTF (partnered with Aarti Industries in February 2026). Actylis also previously operated an API manufacturing facility in Eugene, Oregon (legacy Cascade Chemistry), which was divested to Agno Pharma in January 2026, indicating a strategic refocus toward distribution and specialty ingredient consolidation rather than upstream API production.

The company's go-to-market is sales-led B2B, relying on direct enterprise relationships with manufacturers and quote-based pricing on bulk orders and contracts. Its core technology is supply chain and distribution orchestration rather than proprietary software or AI; competitive positioning rests on portfolio breadth built through acquisitions (notably Pharm-RX) and distribution partnerships that combine manufacturing partners' capacity with Actylis's regional North American reach. The company employs 501–1,000 people and serves the fragmented specialty ingredients supply chain by acting as a consolidating single-source platform, addressing manufacturer pain points around supply security, regulatory compliance for pharma-grade ingredients, and access to a broad specialty ingredient catalog.

Short descriptiontext

Actylis is a B2B specialty ingredients manufacturer and distributor supplying vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to pharmaceutical, nutrition, and industrial chemical manufacturers across North America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPort Washington, United States
HQ citystring
Port Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty ingredients supply, pharmaceutical excipients distribution, active pharmaceutical ingredients, vitamin mineral supplements, specialty chemical distribution
Industry5 codes
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYIMAEABAJ
Personal Care & Cosmetic Ingredients
SECONDARYAFAIAKAI
Food-Grade Additives & Functional Ingredients Trading/Wholesale
Agriculture & Food Production/Food Distribution & Wholesale/Food Ingredients & Commodities Trading/Wholesale
SECONDARYCRAFAHAK
Chemicals, Ingredients & Raw Materials Marketplaces
Consumer Products & Retail/E-commerce & Marketplaces/Wholesale/B2B E-commerce Marketplaces
NAICS code3 codes
  • Chemical and Allied Products Merchant Wholesalers4246
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Medicinal and Botanical Manufacturing325411
SIC code3 codes
  • Wholesale-Chemicals & Allied Products5160
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Specialty Ingredients Manufacturing and Distribution
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Ingredients Sales
TypeOne Time License
Description

Actylis generates revenue through the sale and distribution of specialty ingredients to pharmaceutical, vitamin, mineral, and supplement manufacturers. The company serves as a provider of raw materials and ingredients for the life sciences industry.

finsmes.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Actylis manufactures and distributes specialty raw materials and ingredients—including vitamins, minerals, dietary supplements, pharmaceutical excipients, active pharmaceutical ingredients (APIs), and specialty solvents—for biopharma, cosmetics, chemicals, nutrition, and agriscience manufacturers. The company serves as a B2B ingredient supplier, combining acquired product portfolios (e.g., Pharm-RX) with channel distribution partnerships (e.g., Aarti Industries for PCBTF solvent) to provide manufacturers with a consolidated source for formulation and production inputs.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Actylis is a life sciences and specialty ingredients provider based in NYC. The company operates as a specialty ingredients supplier serving the vitamin, mineral, supplement, pharmaceutical, and nutrition markets. Actylis' portfolio includes acquired brands like Pharm-Rx and specialty chemical distribution services such as PCBTF solvent. The company focuses on expanding its solutions through strategic acquisitions and distribution partnerships to enhance its product portfolio and accelerate growth in nutrition and OTC pharmaceutical markets.

Product and service2 records
1Pharm-RX Specialty Ingredients
CategorySpecialty Ingredients / Nutraceuticals and Pharmaceutical Raw Materials
2PCBTF Solvent Distribution
CategorySpecialty Chemical Distribution
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-11
Description

Actylis has partnered with Aarti Industries Limited to distribute PCBTF solvent across North America. This collaboration combines Aarti's manufacturing capabilities with Actylis's regional distribution network to enhance supply security and market reach for industrial and specialty applications. The partnership aims to support customers requiring specialty solvents with reliable supply and distribution services.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty chemicals and ingredients distributor with a strong focus on life sciences, personal care, food, and pharma — highly comparable value proposition and customer mix to Actylis.

TypeBroad incumbent
Description

Global specialty chemicals business serving microbial control, personal care, and industrial markets. Broader portfolio than Actylis, but comparable B2B specialty ingredients distribution into regulated end-markets.

TypeDirect peer
Description

Global specialty ingredients distributor serving pharma, personal care, food, and industrial markets with a partnership- and acquisition-led growth model similar to Actylis's stated roll-up approach.

TypeDirect peer
Description

Specialty chemical distributor serving industrial, water treatment, and pharma/food customers with a regional distribution focus. Similar mid-sized B2B distribution profile to Actylis.

TypeDirect peer
Description

Specialty ingredients distributor focused on life sciences, personal care, and food markets, with an active acquisition strategy (including the Maroon Group acquisition). Comparable business model and customer base to Actylis.

TypeDirect peer
Description

Specialty chemical and ingredient supplier serving pharmaceutical, nutraceutical, and laboratory customers. Comparable focus on regulated, high-quality ingredients distributed to manufacturers.

7Univar Solutions
TypeDirect peer
Description

One of the largest North American specialty chemical and ingredient distributors, serving pharma, food, personal care, and industrial end-markets. Direct overlap with Actylis's specialty ingredients distribution model and B2B sales-led GTM.

TypeDirect peer
Description

Global market leader in chemical and ingredients distribution with deep pharma, nutrition, personal care, and industrial portfolios. Closely comparable to Actylis across verticals and customer types.

TypeBroad incumbent
Description

Large global ingredient solutions provider for food, beverage, and personal care. Broader and more food-centric than Actylis, but overlapping in ingredient distribution to manufacturers and nutrition customers.

TypeBroad incumbent
Description

Specialty ingredient manufacturer and supplier for pharma, health, nutrition, and industrial markets. Comparable product overlap in excipients and specialty minerals, though more manufacturing-anchored than Actylis's distribution-led model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Actylis

Specialty Ingredients Manufacturing and Distributionactylis.com

Actylis is a B2B specialty ingredients manufacturer and distributor supplying vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to pharmaceutical, nutrition, and industrial chemical manufacturers across North America.

What Actylis does

Actylis is a privately held specialty ingredients manufacturer and distributor serving the life sciences, pharmaceutical, nutrition, and specialty chemical industries. Founded in 2022 and headquartered in New York, the company supplies vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to B2B customers including dietary supplement manufacturers, OTC and prescription pharmaceutical producers, and industrial chemical users across North America. Its product portfolio includes acquired brands such as Pharm-RX (acquired October 2024) and specialty solvent distribution such as PCBTF (partnered with Aarti Industries in February 2026). Actylis also previously operated an API manufacturing facility in Eugene, Oregon (legacy Cascade Chemistry), which was divested to Agno Pharma in January 2026, indicating a strategic refocus toward distribution and specialty ingredient consolidation rather than upstream API production.

The company's go-to-market is sales-led B2B, relying on direct enterprise relationships with manufacturers and quote-based pricing on bulk orders and contracts. Its core technology is supply chain and distribution orchestration rather than proprietary software or AI; competitive positioning rests on portfolio breadth built through acquisitions (notably Pharm-RX) and distribution partnerships that combine manufacturing partners' capacity with Actylis's regional North American reach. The company employs 501–1,000 people and serves the fragmented specialty ingredients supply chain by acting as a consolidating single-source platform, addressing manufacturer pain points around supply security, regulatory compliance for pharma-grade ingredients, and access to a broad specialty ingredient catalog.

Actylis firmographics

Firmographics
Name
Actylis
Website
https://actylis.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
251–500 employees
Short description
Actylis is a B2B specialty ingredients manufacturer and distributor supplying vitamins, minerals, supplements, pharmaceutical excipients, and specialty solvents to pharmaceutical, nutrition, and industrial chemical manufacturers across North America.
Ownership category
akta.pro rank

Actylis industry classification

Industry
Product category
Specialty Ingredients Manufacturing and Distribution
NAICS
Chemical and Allied Products Merchant Wholesalers (4246), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)
SIC
Wholesale-Chemicals & Allied Products (5160), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYIMAEABAJ
Personal Care & Cosmetic Ingredients
SECONDARYAFAIAKAI
Food-Grade Additives & Functional Ingredients Trading/Wholesale
Agriculture & Food Production/Food Distribution & Wholesale/Food Ingredients & Commodities Trading/Wholesale
SECONDARYCRAFAHAK
Chemicals, Ingredients & Raw Materials Marketplaces
Consumer Products & Retail/E-commerce & Marketplaces/Wholesale/B2B E-commerce Marketplaces

Keywords

  • Specialty ingredients supply
  • Pharmaceutical excipients distribution
  • Active pharmaceutical ingredients
  • Vitamin mineral supplements
  • Specialty chemical distribution

Where Actylis is headquartered

Location

Headquarters

HQ city
Port Washington
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Actylis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Specialty Ingredients Sales: Actylis generates revenue through the sale and distribution of specialty ingredients to pharmaceutical, vitamin, mineral, and supplement manufacturers. The company serves as a provider of raw materials and ingredients for the life sciences industry.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Actylis product offering

Product offering

Core offering

Actylis manufactures and distributes specialty raw materials and ingredients—including vitamins, minerals, dietary supplements, pharmaceutical excipients, active pharmaceutical ingredients (APIs), and specialty solvents—for biopharma, cosmetics, chemicals, nutrition, and agriscience manufacturers. The company serves as a B2B ingredient supplier, combining acquired product portfolios (e.g., Pharm-RX) with channel distribution partnerships (e.g., Aarti Industries for PCBTF solvent) to provide manufacturers with a consolidated source for formulation and production inputs.

Product overview

Actylis is a life sciences and specialty ingredients provider based in NYC. The company operates as a specialty ingredients supplier serving the vitamin, mineral, supplement, pharmaceutical, and nutrition markets. Actylis' portfolio includes acquired brands like Pharm-Rx and specialty chemical distribution services such as PCBTF solvent. The company focuses on expanding its solutions through strategic acquisitions and distribution partnerships to enhance its product portfolio and accelerate growth in nutrition and OTC pharmaceutical markets.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharm-RX Specialty Ingredients
  • PCBTF Solvent Distribution

Companies that use Actylis

Customer profile

Segments3 records

Ideal customer profiles3 records

Actylis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Actylis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Aarti Industries LimitedcoreChannel Partner/ Reseller/ Distributor · 11 February 2026Actylis has partnered with Aarti Industries Limited to distribute PCBTF solvent across North America. This collaboration combines Aarti's manufacturing capabilities with Actylis's regional distribution network to enhance supply security and market reach for industrial and specialty applications. The partnership aims to support customers requiring specialty solvents with reliable supply and distribution services.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Actylis competitors and assessment

Company assessment

Direct peers

  • IMCD: Specialty chemicals and ingredients distributor with a strong focus on life sciences, personal care, food, and pharma — highly comparable value proposition and customer mix to Actylis.
  • Azelis: Global specialty ingredients distributor serving pharma, personal care, food, and industrial markets with a partnership- and acquisition-led growth model similar to Actylis's stated roll-up approach.
  • Hawkins: Specialty chemical distributor serving industrial, water treatment, and pharma/food customers with a regional distribution focus. Similar mid-sized B2B distribution profile to Actylis.
  • Barentz: Specialty ingredients distributor focused on life sciences, personal care, and food markets, with an active acquisition strategy (including the Maroon Group acquisition). Comparable business model and customer base to Actylis.
  • Spectrum Chemical: Specialty chemical and ingredient supplier serving pharmaceutical, nutraceutical, and laboratory customers. Comparable focus on regulated, high-quality ingredients distributed to manufacturers.
  • Univar Solutions: One of the largest North American specialty chemical and ingredient distributors, serving pharma, food, personal care, and industrial end-markets. Direct overlap with Actylis's specialty ingredients distribution model and B2B sales-led GTM.
  • Brenntag: Global market leader in chemical and ingredients distribution with deep pharma, nutrition, personal care, and industrial portfolios. Closely comparable to Actylis across verticals and customer types.

Broad incumbents

  • Arxada: Global specialty chemicals business serving microbial control, personal care, and industrial markets. Broader portfolio than Actylis, but comparable B2B specialty ingredients distribution into regulated end-markets.
  • Ingredion: Large global ingredient solutions provider for food, beverage, and personal care. Broader and more food-centric than Actylis, but overlapping in ingredient distribution to manufacturers and nutrition customers.
  • Innophos: Specialty ingredient manufacturer and supplier for pharma, health, nutrition, and industrial markets. Comparable product overlap in excipients and specialty minerals, though more manufacturing-anchored than Actylis's distribution-led model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Actylis social profiles

Digital presence

Actylis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Actylis leadership team

Management profile

Number of profiles

Profiles3 records

Actylis subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Actylis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Actylis M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Actylis

What does Actylis do?

Actylis manufactures and distributes specialty raw materials and ingredients—including vitamins, minerals, dietary supplements, pharmaceutical excipients, active pharmaceutical ingredients (APIs), and specialty solvents—for biopharma, cosmetics, chemicals, nutrition, and agriscience manufacturers. The company serves as a B2B ingredient supplier, combining acquired product portfolios (e.g., Pharm-RX) with channel distribution partnerships (e.g., Aarti Industries for PCBTF solvent) to provide manufacturers with a consolidated source for formulation and production inputs.

Is Actylis a public or private company?

Actylis is a private company. It is classified as unknown and is currently operating.

When was Actylis founded?

Actylis was founded in 2022. It employs 251 to 500 people.

Where is Actylis based?

Actylis is headquartered in Port Washington, United States, in the North America region.

How does Actylis make money?

One revenue line is on record: specialty Ingredients Sales.

Who are Actylis's main competitors?

Direct peers on record are IMCD, Azelis, Hawkins, Barentz, Spectrum Chemical, Univar Solutions and Brenntag. Broad incumbents are Arxada, Ingredion and Innophos.

Does Actylis have an API?

No public API is recorded for Actylis.

What industry is Actylis in?

Actylis's product category is Specialty Ingredients Manufacturing and Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply). Its NAICS code is 4246 and its SIC code is 5160.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ChemindigestActylis and Aarti Industries Partners for PCBTF Solvent DistributionActylis has partnered with Aarti Industries Limited to distribute PCBTF solvent across North America, aiming to enhance supply security and market reach. The collaboration combines manufacturing capabilities and regional distribution to support industrial and specialty applications.PharmiWeb.comAgno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API Development and Manufacturing CapabilitiesAgno Pharma acquired Actylis Eugene, a small-molecule API development and manufacturing site in Eugene, Oregon, from Actylis. The site includes a large R&D and GMP manufacturing infrastructure, supporting early to late-phase clinical API production.FinSMEsActylis Acquires Pharm-RxActylis announced the strategic acquisition of Pharm-Rx, a Saddle Brook-based supplier of specialty ingredients for the vitamin and pharmaceutical industries. The deal aims to expand Actylis' portfolio and service offerings in the nutrition and over-the-counter sectors, with Pharm-Rx continuing to operate under its current brand. This marks Actylis' eighth acquisition in four years as it seeks to broaden its global sourcing and manufacturing capabilities.YahooActylis Acquires Pharm-Rx, a Leading Value-Added Supplier of Specialty Ingredients for the Vitamin, Mineral, and Supplement and Pharmaceutical IndustriesActylis acquired Pharm-Rx, a value-added supplier of specialty ingredients for vitamin, mineral, and supplement and pharmaceutical industries. The deal expands Actylis' nutraceuticals capabilities and strengthens its supplier partnerships. Mark Bostel will lead the combined nutrition and OTC businesses.Business Wire BlogActylis Acquires Pharm-Rx, a Leading Value-Added Supplier of Specialty Ingredients for the Vitamin, Mineral, and Supplement and Pharmaceutical IndustriesActylis acquired Pharm-Rx, a specialty ingredients supplier for vitamin, mineral, and supplement markets. The deal expands Actylis' portfolio and leadership, with Mark Bostel becoming President of Global Nutrition and OTC. Financial terms were not disclosed.TmcnetActylis Announces Appointment of Scott Thomson as Chief Executive OfficerActylis appointed Scott Thomson as CEO on June 17, 2024, citing his three-decade track record in pharmaceutical and chemical industries, most recently as CEO of SPI Pharma. The company, which completed seven acquisitions since 2019, expects Thomson to accelerate growth in high-growth end markets.MorningstarActylis Announces Appointment of Scott Thomson as Chief Executive OfficerActylis appointed Scott Thomson as CEO, bringing his three-decade track record from SPI Pharma and BASF. The company continues its expansion of integrated global specialty ingredients manufacturing and sourcing. Thomson aims to accelerate growth with New Mountain Capital's support.YahooActylis Announces Appointment of Scott Thomson as Chief Executive OfficerActylis appointed Scott Thomson as CEO, bringing his three-decade pharmaceutical and chemical industry experience, most recently as CEO of SPI Pharma. The company, backed by New Mountain Capital, plans to expand its global reach and accelerate growth in high-growth end markets.ChemicalsknowledgehubActylis, NCS South Africa, and Agni Chemicals Announce Tripartite Partnership to Revolutionize Coating Resins in North America – Chemicals KnowledgeActylis, NCS South Africa, and Agni Chemicals have formed a tripartite partnership to distribute coating resins in North America. Under this agreement, NCS will produce the resins at its facilities in South Africa while Actylis serves as the principal distributor and Agni Chemicals manages supply chain coordination. The alliance aims to provide an alternative sourcing option outside the APAC region with a focus on sustainability and competitive pricing.ActylisCompany AnnouncementsActylis, NCS South Africa and Agni Chemicals announced a tripartite partnership on February 1, 2024 to supply coating resins in North America from a source outside the APAC region. Actylis will be the principal distributor, Agni Chemicals will oversee supply chain coordination, and NCS will produce and supply the resins from its South African facilities. No financial terms were disclosed.